{"title":"血管生物学中血栓素A2受体的表达、结构和功能的研究","authors":"Robert Eckenstaler, and , Ralf A. Benndorf*, ","doi":"10.1021/acsptsci.5c00378","DOIUrl":null,"url":null,"abstract":"<p >The thromboxane A<sub>2</sub> receptor is known for its role in platelet aggregation. In platelets, loss or gain-of-function of the thromboxane A<sub>2</sub> receptor may therefore lead to bleeding disorders or prothrombotic conditions. However, the thromboxane A<sub>2</sub> receptor is also expressed in many other cell types and tissues and is thought to contribute to a broad range of other pathophysiological processes, such as pulmonary hypertension and cancer cell metastasis. In endothelial cells, the thromboxane A<sub>2</sub> receptor is an important player in the pathogenesis of endothelial dysfunction, one of the main contributors to the development of hypertension and atherosclerosis-related diseases. In this review, we provide insight into the genomic structure and expression, protein structure and function of the thromboxane A<sub>2</sub> receptor, with a particular focus on vascular (patho)physiology and recent findings regarding the involvement of thromboxane A<sub>2</sub> receptor signaling in the pathogenesis of endothelial dysfunction and cardiovascular disease. In addition, we provide an overview of clinically relevant polymorphisms within the thromboxane A<sub>2</sub> receptor gene (<i>TBXA2R</i>) and their influence on gene expression, protein structure, and receptor pathophysiology.</p>","PeriodicalId":36426,"journal":{"name":"ACS Pharmacology and Translational Science","volume":"8 9","pages":"2887–2907"},"PeriodicalIF":3.7000,"publicationDate":"2025-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Insights into the Expression, Structure, and Function of the Thromboxane A2 Receptor in Vascular Biology\",\"authors\":\"Robert Eckenstaler, and , Ralf A. Benndorf*, \",\"doi\":\"10.1021/acsptsci.5c00378\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >The thromboxane A<sub>2</sub> receptor is known for its role in platelet aggregation. In platelets, loss or gain-of-function of the thromboxane A<sub>2</sub> receptor may therefore lead to bleeding disorders or prothrombotic conditions. However, the thromboxane A<sub>2</sub> receptor is also expressed in many other cell types and tissues and is thought to contribute to a broad range of other pathophysiological processes, such as pulmonary hypertension and cancer cell metastasis. In endothelial cells, the thromboxane A<sub>2</sub> receptor is an important player in the pathogenesis of endothelial dysfunction, one of the main contributors to the development of hypertension and atherosclerosis-related diseases. In this review, we provide insight into the genomic structure and expression, protein structure and function of the thromboxane A<sub>2</sub> receptor, with a particular focus on vascular (patho)physiology and recent findings regarding the involvement of thromboxane A<sub>2</sub> receptor signaling in the pathogenesis of endothelial dysfunction and cardiovascular disease. In addition, we provide an overview of clinically relevant polymorphisms within the thromboxane A<sub>2</sub> receptor gene (<i>TBXA2R</i>) and their influence on gene expression, protein structure, and receptor pathophysiology.</p>\",\"PeriodicalId\":36426,\"journal\":{\"name\":\"ACS Pharmacology and Translational Science\",\"volume\":\"8 9\",\"pages\":\"2887–2907\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-08-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Pharmacology and Translational Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsptsci.5c00378\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Pharmacology and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsptsci.5c00378","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Insights into the Expression, Structure, and Function of the Thromboxane A2 Receptor in Vascular Biology
The thromboxane A2 receptor is known for its role in platelet aggregation. In platelets, loss or gain-of-function of the thromboxane A2 receptor may therefore lead to bleeding disorders or prothrombotic conditions. However, the thromboxane A2 receptor is also expressed in many other cell types and tissues and is thought to contribute to a broad range of other pathophysiological processes, such as pulmonary hypertension and cancer cell metastasis. In endothelial cells, the thromboxane A2 receptor is an important player in the pathogenesis of endothelial dysfunction, one of the main contributors to the development of hypertension and atherosclerosis-related diseases. In this review, we provide insight into the genomic structure and expression, protein structure and function of the thromboxane A2 receptor, with a particular focus on vascular (patho)physiology and recent findings regarding the involvement of thromboxane A2 receptor signaling in the pathogenesis of endothelial dysfunction and cardiovascular disease. In addition, we provide an overview of clinically relevant polymorphisms within the thromboxane A2 receptor gene (TBXA2R) and their influence on gene expression, protein structure, and receptor pathophysiology.
期刊介绍:
ACS Pharmacology & Translational Science publishes high quality, innovative, and impactful research across the broad spectrum of biological sciences, covering basic and molecular sciences through to translational preclinical studies. Clinical studies that address novel mechanisms of action, and methodological papers that provide innovation, and advance translation, will also be considered. We give priority to studies that fully integrate basic pharmacological and/or biochemical findings into physiological processes that have translational potential in a broad range of biomedical disciplines. Therefore, studies that employ a complementary blend of in vitro and in vivo systems are of particular interest to the journal. Nonetheless, all innovative and impactful research that has an articulated translational relevance will be considered.
ACS Pharmacology & Translational Science does not publish research on biological extracts that have unknown concentration or unknown chemical composition.
Authors are encouraged to use the pre-submission inquiry mechanism to ensure relevance and appropriateness of research.